Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
13
DTIL Quote, Financials, Valuation and Earnings
Last price:
$4.64
Seasonality move
:
-22.75%
Day range:
$4.27 - $4.57
52-week range:
$3.61 - $11.09
Dividend yield:
0%
P/E ratio:
3.41x
P/S ratio:
0.70x
P/B ratio:
1.02x
Volume:
320.7K
Avg. volume:
411.9K
1-year change:
-56.45%
Market cap:
$50.1M
Revenue:
$68.7M
EPS (TTM):
-$2.53
Earnings Data
Next earnings date for DTIL
Aug 01
2025
Most recent earnings per share
-$2.21
Beat by $0.21
(May 15/2025)
Consensus Estimate
-$2.42
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DTIL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $5.4M | -- | -- | -$2.24 | -- |
| 08/01/2025 | Q2 | $6.3M | -- | -- | -$2.21 | -- |
| 05/15/2025 | Q1 | $5M | $29K | -$2.21 | -$2.42 | $0.21 |
| 03/26/2025 | Q4 | $4.3M | $638K | -$2.74 | -$2.95 | $0.21 |
| 11/04/2024 | Q3 | $6.8M | $576K | -$2.25 | -$3.13 | $0.88 |
| 08/01/2024 | Q2 | $8.3M | $49.9M | $4.67 | -$5.07 | $9.74 |
| 05/13/2024 | Q1 | $6M | $17.6M | $1.70 | -- | -- |
| 03/27/2024 | Q4 | $14.5M | $7M | -$4.06 | -- | -- |
| 11/07/2023 | Q3 | $10.2M | $13.1M | -$2.10 | -- | -- |
| 08/04/2023 | Q2 | $7.3M | $19.8M | -$3.13 | -$7.50 | $4.37 |
| 05/09/2023 | Q1 | -- | $8.8M | -$6.75 | -- | -- |
| 03/09/2023 | Q4 | -- | $10.6M | -$7.80 | -- | -- |
| 11/08/2022 | Q3 | -- | $7.4M | -$6.60 | -- | -- |
| 08/08/2022 | Q2 | -- | $3.8M | -$13.80 | -- | -- |
| 05/09/2022 | Q1 | -- | $3.3M | -$13.80 | -- | -- |
| 03/15/2022 | Q4 | -- | $6.3M | -$11.40 | -- | -- |
| 11/10/2021 | Q3 | -- | $24M | -$5.70 | -- | -- |
| 08/12/2021 | Q2 | -- | $68.8M | $10.80 | -- | -- |
| 05/13/2021 | Q1 | -- | $16.3M | -$9.90 | -- | -- |
| 03/18/2021 | Q4 | -- | $8.8M | -$13.20 | -- | -- |
| 11/10/2020 | Q3 | -- | $7.4M | -$15.00 | -- | -- |
| 08/13/2020 | Q2 | -- | $1.1M | -$18.90 | -- | -- |
| 05/15/2020 | Q1 | -- | $7M | -$15.60 | -- | -- |
| 03/10/2020 | Q4 | -- | $6.5M | -$10.80 | -- | -- |
| 11/12/2019 | Q3 | -- | $4.9M | -$12.30 | -- | -- |
| 08/14/2019 | Q2 | -- | $5.4M | -$11.70 | -- | -- |
| 04/29/2019 | Q1 | -- | $5.5M | -$59.70 | -- | -- |
| 12/31/2018 | Q4 | -- | $4.9M | -$9.45 | -- | -- |
| 09/30/2018 | Q3 | -- | $2.5M | -$8.70 | -- | -- |
| 06/30/2018 | Q2 | -- | $1.9M | -$10.54 | -- | -- |
| 03/31/2018 | Q1 | -- | $1.5M | -$8.03 | -- | -- |
Precision BioSciences Earnings Questions
-
How Much did Precision BioSciences Generate in Revenue Last Quarter?
Precision BioSciences reported $29K worth of top line sales in its most recent quarter.
-
Did Precision BioSciences Beat Earnings Last Quarter?
Precision BioSciences announced earnings per share of -$2.21 which represents a beat of analyst forecast a -$2.42 per share.
-
Is Precision BioSciences Profitable?
Precision BioSciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Precision BioSciences EPS Next Year?
Precision BioSciences's earnings are forecast to decrease from $1.04 per share to $1.03 per share next year representing a decrease of -57.39%.
-
When is Precision BioSciences's Earnings Date?
Precision BioSciences's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
